A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors

Molecular cancer therapeutics

Chester E Chamberlain, Michael S German, Katherine Yang, …, Danny Lee, Yucheng Wang, Eric K Nakakura

• DOI: 10.1158/1535-7163.mct-17-1204
• PMID: 30254185
• PMCID: PMC6279485